<pmc-articleset>
  <article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="brief-report" xml:lang="en" dtd-version="1.4">
    <front>
      <journal-meta>
        <journal-id journal-id-type="nlm-ta">J Pathol Clin Res</journal-id>
        <journal-id journal-id-type="iso-abbrev">J Pathol Clin Res</journal-id>
        <journal-id journal-id-type="pmc-domain-id">2938</journal-id>
        <journal-id journal-id-type="pmc-domain">cjp</journal-id>
        <journal-id journal-id-type="publisher-id">CJP2</journal-id>
        <journal-title-group>
          <journal-title>The Journal of Pathology: Clinical Research</journal-title>
        </journal-title-group>
        <issn pub-type="epub">2056-4538</issn>
        <publisher>
          <publisher-name>Wiley</publisher-name>
        </publisher>
      </journal-meta>
      <article-meta>
        <article-id pub-id-type="pmcid">PMC7869928</article-id>
        <article-id pub-id-type="pmcid-ver">PMC7869928.1</article-id>
        <article-id pub-id-type="pmcaid">7869928</article-id>
        <article-id pub-id-type="pmcaiid">7869928</article-id>
        <article-id pub-id-type="pmid">33263939</article-id>
        <article-id pub-id-type="doi">10.1002/cjp2.190</article-id>
        <article-id pub-id-type="publisher-id">CJP2190</article-id>
        <article-version article-version-type="pmc-version">1</article-version>
        <article-categories>
          <subj-group subj-group-type="overline">
            <subject>Brief Report</subject>
          </subj-group>
          <subj-group subj-group-type="heading">
            <subject>Brief Report</subject>
          </subj-group>
        </article-categories>
        <title-group>
          <article-title>
<styled-content style="fixed-case" toggle="no">Whole‐exome</styled-content> sequencing analysis of juvenile papillomatosis and coexisting breast carcinoma</article-title>
          <alt-title alt-title-type="right-running-head">Juvenile papillomatosis and breast cancer</alt-title>
          <alt-title alt-title-type="left-running-head">TM D'Alfonso, F Pareja, A Da Cruz Paula, M Vahdatinia <italic toggle="yes">et al</italic></alt-title>
        </title-group>
        <contrib-group>
          <contrib id="cjp2190-cr-0001" contrib-type="author">
            <name name-style="western">
              <surname>D'Alfonso</surname>
              <given-names initials="TM">Timothy M</given-names>
            </name>
            <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0464-0868</contrib-id>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
            <xref ref-type="author-notes" rid="cjp2190-note-0001">
<sup>†</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0002" contrib-type="author" corresp="yes">
            <name name-style="western">
              <surname>Pareja</surname>
              <given-names initials="F">Fresia</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
            <xref ref-type="author-notes" rid="cjp2190-note-0001">
<sup>†</sup>
</xref>
            <address>
              <email>parejaf@mskcc.org</email>
            </address>
          </contrib>
          <contrib id="cjp2190-cr-0003" contrib-type="author">
            <name name-style="western">
              <surname>Da Cruz Paula</surname>
              <given-names initials="A">Arnaud</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0002">
<sup>2</sup>
</xref>
            <xref ref-type="author-notes" rid="cjp2190-note-0001">
<sup>†</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0004" contrib-type="author">
            <name name-style="western">
              <surname>Vahdatinia</surname>
              <given-names initials="M">Mahsa</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
            <xref ref-type="author-notes" rid="cjp2190-note-0001">
<sup>†</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0005" contrib-type="author">
            <name name-style="western">
              <surname>Gazzo</surname>
              <given-names initials="A">Andrea</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0006" contrib-type="author">
            <name name-style="western">
              <surname>Ferrando</surname>
              <given-names initials="L">Lorenzo</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0003">
<sup>3</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0007" contrib-type="author">
            <name name-style="western">
              <surname>da Silva</surname>
              <given-names initials="EM">Edaise M</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0008" contrib-type="author">
            <name name-style="western">
              <surname>Cheng</surname>
              <given-names initials="E">Esther</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0004">
<sup>4</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0009" contrib-type="author">
            <name name-style="western">
              <surname>Sclafani</surname>
              <given-names initials="L">Lisa</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0002">
<sup>2</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0010" contrib-type="author">
            <name name-style="western">
              <surname>Chandarlapaty</surname>
              <given-names initials="S">Sarat</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0005">
<sup>5</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0011" contrib-type="author">
            <name name-style="western">
              <surname>Zhang</surname>
              <given-names initials="H">Hong</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0012" contrib-type="author">
            <name name-style="western">
              <surname>Hoda</surname>
              <given-names initials="SA">Syed A</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0004">
<sup>4</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0013" contrib-type="author">
            <name name-style="western">
              <surname>Wen</surname>
              <given-names initials="HY">Hannah Y</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0014" contrib-type="author">
            <name name-style="western">
              <surname>Brogi</surname>
              <given-names initials="E">Edi</given-names>
            </name>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0015" contrib-type="author">
            <name name-style="western">
              <surname>Weigelt</surname>
              <given-names initials="B">Britta</given-names>
            </name>
            <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9927-1270</contrib-id>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
          </contrib>
          <contrib id="cjp2190-cr-0016" contrib-type="author" corresp="yes">
            <name name-style="western">
              <surname>Reis‐Filho</surname>
              <given-names initials="JS">Jorge S</given-names>
            </name>
            <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2969-3173</contrib-id>
            <xref ref-type="aff" rid="cjp2190-aff-0001">
<sup>1</sup>
</xref>
            <address>
              <email>reisfilj@mskcc.org</email>
            </address>
          </contrib>
        </contrib-group>
        <aff id="cjp2190-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Pathology</named-content>
<institution>Memorial Sloan Kettering Cancer Center</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
        <aff id="cjp2190-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Surgery</named-content>
<institution>Memorial Sloan Kettering Cancer Center</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
        <aff id="cjp2190-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Internal Medicine</named-content>
<institution>University of Genoa</institution>
<city>Genoa</city>
<country country="IT">Italy</country>
</aff>
        <aff id="cjp2190-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Pathology and Laboratory Medicine</named-content>
<institution>Weill Cornell Medicine</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
        <aff id="cjp2190-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">Department of Medicine</named-content>
<institution>Memorial Sloan Kettering Cancer Center</institution>
<city>New York</city>
<named-content content-type="country-part">NY</named-content>
<country country="US">USA</country>
</aff>
        <author-notes>
          <corresp id="correspondenceTo"><label>*</label>
Correspondence: Fresia Pareja and Jorge S Reis‐Filho, Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. E‐mail: <email>parejaf@mskcc.org</email> (FP); <email>reisfilj@mskcc.org</email> (JSR‐F)<break/></corresp>
          <fn id="cjp2190-note-0001" fn-type="equal">
            <label>†</label>
            <p>These authors contributed equally to this work.</p>
          </fn>
        </author-notes>
        <pub-date pub-type="epub">
          <day>02</day>
          <month>12</month>
          <year>2020</year>
        </pub-date>
        <pub-date pub-type="collection">
          <month>3</month>
          <year>2021</year>
        </pub-date>
        <volume>7</volume>
        <issue>2</issue>
        <issue-id pub-id-type="pmc-issue-id">374973</issue-id>
        <issue-id pub-id-type="doi">10.1002/cjp2.v7.2</issue-id>
        <fpage>113</fpage>
        <lpage>120</lpage>
        <history>
          <date date-type="received">
            <day>24</day>
            <month>9</month>
            <year>2020</year>
          </date>
          <date date-type="rev-recd">
            <day>08</day>
            <month>10</month>
            <year>2020</year>
          </date>
          <date date-type="accepted">
            <day>16</day>
            <month>10</month>
            <year>2020</year>
          </date>
        </history>
        <pub-history>
          <event event-type="pmc-release">
            <date>
              <day>02</day>
              <month>12</month>
              <year>2020</year>
            </date>
          </event>
          <event event-type="pmc-live">
            <date>
              <day>17</day>
              <month>02</month>
              <year>2021</year>
            </date>
          </event>
          <event event-type="pmc-last-change">
            <date iso-8601-date="2021-02-18 00:16:21.943">
              <day>18</day>
              <month>02</month>
              <year>2021</year>
            </date>
          </event>
        </pub-history>
        <permissions>
          <copyright-statement content-type="article-copyright">© 2020 The Authors. <italic toggle="yes">The Journal of Pathology: Clinical Research</italic> published by The Pathological Society of Great Britain and Ireland &amp; John Wiley &amp; Sons, Ltd.</copyright-statement>
          <license license-type="creativeCommonsBy">
            <license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
          </license>
        </permissions>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CJP2-7-113.pdf"/>
        <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CJP2-7-113.pdf"/>
        <abstract>
          <title>Abstract</title>
          <p>Juvenile papillomatosis (JP) of the breast is a rare benign mass‐forming lesion occurring in young women, which is histologically characterized by a constellation of proliferative changes and large cysts, giving it the gross appearance of Swiss cheese. A subset of patients with JP report a family history of breast carcinoma and/or coexisting or subsequent breast carcinoma. We performed whole‐exome sequencing of the hyperplastic epithelial component of three JPs, including one with coexisting ductal carcinoma <italic toggle="yes">in situ</italic> (DCIS) and invasive ductal carcinoma of no special type (IDC‐NST). JPs harbored clonal somatic <italic toggle="yes">PIK3CA</italic> hotspot mutations in two cases. In the JP with coexisting DCIS and IDC‐NST, these lesions were clonally related to the associated JP, sharing a clonal <italic toggle="yes">PIK3CA</italic> E542K somatic hotspot mutation. JP showed a paucity of copy number alterations, whereas the associated DCIS and IDC‐NST showed concurrent 1q gains/16q losses, hallmarks of estrogen receptor (ER)‐positive breast cancers. We observed JP to harbor a dominant aging‐related mutational signature, whereas coexisting DCIS and IDC‐NST showed greater exposure to an APOBEC signature. Taken together, our findings suggest that, at least in a subset of cases, JP might constitute the substrate from which DCIS and invasive breast carcinomas develop.</p>
        </abstract>
        <kwd-group kwd-group-type="author-generated">
          <kwd id="cjp2190-kwd-0001">juvenile papillomatosis</kwd>
          <kwd id="cjp2190-kwd-0002">
            <italic toggle="yes">PIK3CA</italic>
          </kwd>
          <kwd id="cjp2190-kwd-0003">breast carcinoma</kwd>
        </kwd-group>
        <funding-group>
          <award-group id="funding-0001">
            <funding-source>
              <institution-wrap>
                <institution>Breast Cancer Research Foundation </institution>
                <institution-id institution-id-type="open-funder-registry">10.13039/100001006</institution-id>
              </institution-wrap>
            </funding-source>
          </award-group>
          <award-group id="funding-0002">
            <funding-source>Cycle for Survival</funding-source>
          </award-group>
          <award-group id="funding-0003">
            <funding-source>
              <institution-wrap>
                <institution>National Cancer Institute </institution>
                <institution-id institution-id-type="open-funder-registry">10.13039/100000054</institution-id>
              </institution-wrap>
            </funding-source>
            <award-id>K12 CA184746</award-id>
            <award-id>P30CA008748</award-id>
          </award-group>
          <award-group id="funding-0004">
            <funding-source>
              <institution-wrap>
                <institution>Stand Up To Cancer </institution>
                <institution-id institution-id-type="open-funder-registry">10.13039/100009730</institution-id>
              </institution-wrap>
            </funding-source>
          </award-group>
        </funding-group>
        <counts>
          <fig-count count="3"/>
          <table-count count="0"/>
          <page-count count="8"/>
          <word-count count="4535"/>
        </counts>
        <custom-meta-group>
          <custom-meta>
            <meta-name>pmc-status-qastatus</meta-name>
            <meta-value>0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-live</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-embargo</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-status-released</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-open-access</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-olf</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-manuscript</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-legally-suppressed</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-pdf</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-has-supplement</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-pdf-only</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-suppress-copyright</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-real-version</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-is-scanned-article</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-preprint</meta-name>
            <meta-value>no</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>pmc-prop-in-epmc</meta-name>
            <meta-value>yes</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>source-schema-version-number</meta-name>
            <meta-value>2.0</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>cover-date</meta-name>
            <meta-value>March 2021</meta-value>
          </custom-meta>
          <custom-meta>
            <meta-name>details-of-publishers-convertor</meta-name>
            <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.9.7 mode:remove_FC converted:08.02.2021</meta-value>
          </custom-meta>
        </custom-meta-group>
      </article-meta>
      <notes>
        <fn-group id="cjp2190-ntgp-0001">
          <fn id="cjp2190-note-0002">
            <p>Conflict of interest statement: JSR‐F reports receiving personal/consultancy fees from Goldman Sachs and REPARE Therapeutics, membership of the scientific advisory boards of VolitionRx and Paige.AI, and ad hoc membership of the scientific advisory boards of Roche Tissue Diagnostics, Ventana Medical Systems, Novartis, Genentech and InVicro, outside the scope of this study. SC has received research support from Daichi Sankyo and consulting fees from Novartis, Sermonix, BMS, Context Therapeutics, Revolution Medicine, Paige AI, and Eli Lilly. HZ reports receiving consultancy fee from Genentech/Roche. The remaining authors declare no conflicts of interest.</p>
          </fn>
        </fn-group>
      </notes>
    </front>
    <body id="cjp2190-body-0001">
      <sec id="cjp2190-sec-0001">
        <title>Introduction</title>
        <p>Juvenile papillomatosis of the breast (JP) is a rare benign mass‐forming lesion usually occurring in women in their 20s to 30s that often mimics fibroadenoma clinically [<xref rid="cjp2190-bib-0001" ref-type="ref">1</xref>, <xref rid="cjp2190-bib-0002" ref-type="ref">2</xref>]. Histologically, JP is characterized by a constellation of proliferative and nonproliferative changes, the most distinct being abundant large cysts, giving the gross appearance of Swiss cheese [<xref rid="cjp2190-bib-0001" ref-type="ref">1</xref>]. Since the description of JP as a distinct entity by Rosen [<xref rid="cjp2190-bib-0001" ref-type="ref">1</xref>], multiple studies have reported a significant family history of breast carcinoma cancer in patients developing JP [<xref rid="cjp2190-bib-0002" ref-type="ref">2</xref>, <xref rid="cjp2190-bib-0003" ref-type="ref">3</xref>, <xref rid="cjp2190-bib-0004" ref-type="ref">4</xref>], suggesting a relationship between JP and breast carcinoma. Furthermore, patients with JP have coexisting breast carcinoma or subsequently develop carcinoma in approximately 10% of cases [<xref rid="cjp2190-bib-0004" ref-type="ref">4</xref>, <xref rid="cjp2190-bib-0005" ref-type="ref">5</xref>]. Recently, Guillet <italic toggle="yes">et al</italic> reported recurrent <italic toggle="yes">PIK3CA</italic> or <italic toggle="yes">AKT1</italic> hotspot mutations in benign JP lesions in the first published study of the molecular features of JP, expanding the spectrum of benign breast lesions with these mutations [<xref rid="cjp2190-bib-0003" ref-type="ref">3</xref>]. Nonetheless, the genetic relationship between JP and coexisting breast carcinoma has not yet been documented. Herein, we sought to characterize the repertoire of genetic alterations of JP by whole‐exome sequencing (WES) and to study the clonal relationship between JP, ductal carcinoma <italic toggle="yes">in situ</italic> (DCIS), and invasive carcinoma in one case where these components coexisted.</p>
      </sec>
      <sec id="cjp2190-sec-0002">
        <title>Materials and methods</title>
        <sec id="cjp2190-sec-0003">
          <title>Subjects and samples</title>
          <p>Following approval from the Institutional Review Boards (IRB), formalin‐fixed paraffin‐embedded tissue blocks were retrieved from the pathology archives of the authors' institutions. Patient consents were obtained if required by the IRB protocols of the different institutions. Samples were anonymized prior to tissue processing. Our cohort included three JP lesions (JuP1, JuP2, and JuP3), including one case (JuP3) with coexisting invasive ductal carcinoma of no special type (IDC‐NST) and DCIS. Slides were reviewed by three pathologists (TMD, FP, and MV). The hyperplastic epithelial components of JP, and DCIS and IDC‐NST components of case JuP3 were separately microdissected from 10 to 15 8‐μm thick histological sections under a stereomicroscope (Olympus SZ61, Tokyo, Japan), as previously described [<xref rid="cjp2190-bib-0006" ref-type="ref">6</xref>]. DNA was extracted from lesion/tumor and matched benign non‐hyperplastic breast parenchyma away from the JP using the DNAeasy Blood and Tissue Kit (Qiagen, Hilden, Germany), following manufacturers' instructions. DNA samples were subjected to WES at the Integrated Genomics Operation at Memorial Sloan Kettering Cancer Center and analyzed.</p>
        </sec>
        <sec id="cjp2190-sec-0004">
          <title>Whole‐exome sequencing analysis</title>
          <p>Reads were aligned to the reference human genome GRCh37 using the Burrows‐Wheeler Aligner (BWA v0.7.15) [<xref rid="cjp2190-bib-0007" ref-type="ref">7</xref>]. The Genome Analysis Toolkit (GATK. V3.1.1) [<xref rid="cjp2190-bib-0008" ref-type="ref">8</xref>] was employed for local realignment, duplicate removal and base quality recalibration. Somatic single nucleotide variants (SNVs) were detected with MuTect (v1.0) [<xref rid="cjp2190-bib-0009" ref-type="ref">9</xref>], indels with Strelka (v2.0.15) [<xref rid="cjp2190-bib-0010" ref-type="ref">10</xref>], Varscan2 (v2.3.7) [<xref rid="cjp2190-bib-0011" ref-type="ref">11</xref>], Scalpel (v0.5.3) [<xref rid="cjp2190-bib-0012" ref-type="ref">12</xref>], and Lancet (v1.0.0) [<xref rid="cjp2190-bib-0013" ref-type="ref">13</xref>] as previously described [<xref rid="cjp2190-bib-0006" ref-type="ref">6</xref>]. SNVs and indels outside of the target regions were filtered out, as were SNVs and indels for which the variant allele fraction (VAF) in the tumor sample was &lt;5 times that of the paired normal VAF, and SNVs and indels found at &gt;5% global minor allele frequency of dbSNP (build 137), as previously described [<xref rid="cjp2190-bib-0014" ref-type="ref">14</xref>]. Only somatic mutations with a depth ≥20 reads in the respective normal samples were considered [<xref rid="cjp2190-bib-0014" ref-type="ref">14</xref>]. All mutations were manually inspected using the Integrative Genomics Viewer (IGV) [<xref rid="cjp2190-bib-0015" ref-type="ref">15</xref>]. The cancer cell fraction (CCF) of each mutation was inferred using ABSOLUTE (v1.0.6) [<xref rid="cjp2190-bib-0016" ref-type="ref">16</xref>], as previously described [<xref rid="cjp2190-bib-0017" ref-type="ref">17</xref>, <xref rid="cjp2190-bib-0018" ref-type="ref">18</xref>]. Mutations were cataloged as clonal if their probability of being clonal was &gt;50% [<xref rid="cjp2190-bib-0019" ref-type="ref">19</xref>], or if the lower bound of the 95% CI of its CCF was &gt;90% [<xref rid="cjp2190-bib-0020" ref-type="ref">20</xref>]. Copy number alterations and loss of heterozygosity were determined using FACETS [<xref rid="cjp2190-bib-0021" ref-type="ref">21</xref>]. Mutations targeting hotspot loci [<xref rid="cjp2190-bib-0022" ref-type="ref">22</xref>] were annotated as previously described [<xref rid="cjp2190-bib-0020" ref-type="ref">20</xref>]. Mutational signatures were inferred using SigMA [<xref rid="cjp2190-bib-0023" ref-type="ref">23</xref>] based on all synonymous and nonsynonymous somatic mutations, as previously reported [<xref rid="cjp2190-bib-0024" ref-type="ref">24</xref>]. A mutation‐based phylogenetic tree of the JP and associated DCIS and IDC‐NST of case JuP3 was constructed using Treeomics [<xref rid="cjp2190-bib-0025" ref-type="ref">25</xref>], based on all synonymous and nonsynonymous mutations identified. Mutations were considered shared when present in different histologic components, and private when present in only one of the components. Clonal relatedness between the JP and coexisting DCIS and IDC‐NST of case JuP3 were assessed using ‘clonality index’ (CI), which is the probability of the mutations shared between different lesions not co‐occurring by chance [<xref rid="cjp2190-bib-0026" ref-type="ref">26</xref>, <xref rid="cjp2190-bib-0027" ref-type="ref">27</xref>]. We used a previously established method [<xref rid="cjp2190-bib-0026" ref-type="ref">26</xref>, <xref rid="cjp2190-bib-0027" ref-type="ref">27</xref>], where CI is defined as follows: <mml:math id="nlm-math-1"><mml:mi mathvariant="italic">CI</mml:mi><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>log</mml:mi><mml:mn>10</mml:mn></mml:msub><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mi>P</mml:mi><mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mi>X</mml:mi></mml:mfenced><mml:mi>m</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:math> The probability of identifying a given mutation in two samples is defined by the binomial probability <italic toggle="yes">P</italic>(<italic toggle="yes">X</italic>) = <italic toggle="yes">C</italic>
<sup><italic toggle="yes">k</italic></sup>
<sub><italic toggle="yes">n</italic></sub>
<italic toggle="yes">p</italic>
<sup><italic toggle="yes">k</italic></sup>(1 − <italic toggle="yes">p</italic>)<sup><italic toggle="yes">n</italic>−k</sup>, <italic toggle="yes">n</italic> = 2, <italic toggle="yes">k</italic> = 2, where <italic toggle="yes">p</italic> represents the frequency of a given mutation and <italic toggle="yes">n</italic> represents the number of shared mutations in different components or the average number of mutations identified in the samples. Hence, the probability of identifying a certain set of <italic toggle="yes">M</italic> identical mutations in the different samples is given by <mml:math id="nlm-math-2"><mml:munderover><mml:mo>∏</mml:mo><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:mi>P</mml:mi><mml:msub><mml:mfenced close=")" open="(" separators=""><mml:mi>X</mml:mi></mml:mfenced><mml:mi>m</mml:mi></mml:msub></mml:math>.</p>
        </sec>
      </sec>
      <sec id="cjp2190-sec-0005">
        <title>Results</title>
        <p>Case JuP1 was a 43‐year‐old woman without a history of breast carcinoma who presented with a palpable breast mass. She underwent lumpectomy that showed JP. Case JuP2 was a 31‐year‐old woman with a family history of breast carcinoma who was found to have clustered calcifications on screening mammogram. Following biopsies showing fibrocystic changes, she underwent lumpectomy showing JP. JuP3 was a 34‐year‐old woman with a family history of breast carcinoma and a history of fibrocystic changes. Ultrasound revealed an irregular hypoechoic mass that was biopsied revealing IDC‐NST and DCIS. She underwent lumpectomy showing JP in association with the carcinoma.</p>
        <p>All cases showed classic histologic features of JP including abundant large cysts, ducts with lipid‐laden histiocytes, florid usual ductal hyperplasia, and apocrine metaplasia/hyperplasia (Figure <xref rid="cjp2190-fig-0001" ref-type="fig">1A,B</xref>). Stromal sclerosis, papilloma/papillary hyperplasia, adenosis, and microcalcifications were present in varying degrees among cases. JuP3 showed a 1.5 cm estrogen receptor (ER)‐positive/HER2‐negative moderately‐differentiated IDC‐NST and DCIS with intermediate to high nuclear grade and necrosis that was intimately associated with benign JP components (Figure <xref rid="cjp2190-fig-0002" ref-type="fig">2A–D</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="cjp2190-fig-0001" orientation="portrait" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Histologic features and repertoire of genetic alterations of JP. (A) Representative micrographs of H&amp;E stained sections of JP illustrating the characteristic cystic cut surface (left) and florid hyperplasia with papillary and apocrine features with calcifications (right). Scale bars: left, 2 mm; right, 500 μm. (B) Genome plots depicting Log<sub>2</sub> ratios (<italic toggle="yes">y</italic>‐axis) plotted according to their genomic positions (<italic toggle="yes">x</italic>‐axis). (C) Heatmaps depicting the nonsynonymous somatic mutations identified by whole‐exome sequencing (left) and cancer cell fraction (CCF) (right). Cases are shown in columns and genes in rows. Mutations and CCF are color‐coded according to the legend. (D) Pie charts showing the mutational signatures as inferred by SigMA. The numbers of synonymous and nonsynonymous mutations of each JP lesion are shown in parentheses.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-1" position="float" orientation="portrait" xlink:href="CJP2-7-113-g001.jpg"/>
        </fig>
        <fig fig-type="Figure" xml:lang="en" id="cjp2190-fig-0002" orientation="portrait" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Histologic images of JP and synchronously identified invasive breast carcinoma and DCIS. (A) Representative micrographs of H&amp;E stained sections of JP showing the cystic cut surface and (B) synchronously identified DCIS and IDC‐NST of case JuP3. (C) Higher power magnification shows DCIS adjacent to the IDC‐NST, showing a moderately differentiated IDC‐NST and intermediate‐grade DCIS. (D) Representative micrograph of the ER immunohistochemical analysis showing strong positive staining in IDC‐NST and DCIS. Scale bars: A: 1 mm; B: 3 mm; C, D: 100 μm.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-3" position="float" orientation="portrait" xlink:href="CJP2-7-113-g002.jpg"/>
        </fig>
        <p>To determine the repertoire of genetic alterations underpinning JP we subjected these three cases to WES. Our analysis revealed that JP shows a paucity of copy number alterations (CNAs) and somatic mutations (Figure <xref rid="cjp2190-fig-0001" ref-type="fig">1B,C</xref>). Benign JP showed a median of 9 (range, 6–25) total and 6 (range, 3–18) nonsynonymous mutations. We identified somatic clonal <italic toggle="yes">PIK3CA</italic> hotspot mutations in cases JuP2 (H1047R) and JuP3 (E542K). Interestingly, JuP1 was found to harbor a germline <italic toggle="yes">PIK3CA</italic> I391M variant, whose significance is uncertain. No other genes were found to be recurrently mutated. We inferred the mutational signatures using SigMA [<xref rid="cjp2190-bib-0023" ref-type="ref">23</xref>] using all synonymous and nonsynonymous somatic mutations. We observed that mutational signatures ascribed to aging (signatures 1 and 5) were dominant in JuP2 and JuP3 (Figure <xref rid="cjp2190-fig-0001" ref-type="fig">1D</xref>). In JuP1, signature 5 (aging) was the second most dominant following signature 18, of cryptic origin (Figure <xref rid="cjp2190-fig-0001" ref-type="fig">1D</xref>).</p>
        <p>As a hypothesis generating aim, we sought to determine whether JP could constitute a substrate for the development of breast carcinoma and conducted WES analysis of the separately microdissected JP and coexisting DCIS and IDC‐NST of JuP3. Our analyses revealed that, although the JP component of JuP3 displayed a paucity of CNAs, the synchronously identified DCIS and IDC‐NST showed concurrent 1q gains/16q losses, the hallmark genetic alteration of ER‐positive breast cancer [<xref rid="cjp2190-bib-0028" ref-type="ref">28</xref>] (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3A</xref>). We observed that the DCIS and IDC‐NST of JuP3 were clonally related to adjacent JP and shared a clonal <italic toggle="yes">PIK3CA</italic> E542K hotspot mutation and <italic toggle="yes">CES1</italic> (S12A) and <italic toggle="yes">SMG1</italic> (R420Q) missense mutations (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3B,C</xref>). DCIS and IDC‐NST shared 29 synonymous and nonsynonymous mutations not seen in JP, including a truncating mutation in the chromatin remodeling gene <italic toggle="yes">ARID1A</italic>, missense mutations in <italic toggle="yes">KMT2C</italic> and <italic toggle="yes">PIK3CB</italic>, and an E14K hotspot mutation affecting <italic toggle="yes">NUP93</italic>, a nucleoporin implicated in cell migration [<xref rid="cjp2190-bib-0029" ref-type="ref">29</xref>] (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3B,C</xref>). A subset of mutations found to be subclonal in the DCIS became dominant in the IDC‐NST, including a <italic toggle="yes">PIK3C2A</italic> missense mutation, suggesting that a minor subclone of the DCIS became the dominant clone in the progression from DCIS to invasive breast cancer (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3B,C</xref>). The DCIS and IDC‐NST subsequently acquired somatic mutations, with the acquisition of a truncating mutation in the tumor suppressor <italic toggle="yes">STAG2</italic> in DCIS and an <italic toggle="yes">FGF12</italic> missense mutation in IDC‐NST (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3B,C</xref>).</p>
        <fig fig-type="Figure" xml:lang="en" id="cjp2190-fig-0003" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>JP and coexisting breast cancer are clonally related. (A) Genome plots depicting Log<sub>2</sub> ratios (<italic toggle="yes">y</italic>‐axis) plotted according to their genomic positions (<italic toggle="yes">x</italic>‐axis). (B) Pairwise comparison of the clonality index (CI) based on somatic mutations identified in JP lesions JuP1, JuP2 and JuP3 and ductal carcinoma <italic toggle="yes">in situ</italic> (JuP3‐DCIS) and invasive ductal carcinoma (JuP3‐IDC) coexisting with JuP3 identified by whole exome sequencing. (C) Heatmaps depicting the nonsynonymous somatic mutations identified in the different histologic components of case JuP3 (left) and their cancer cell fraction (CCF) (right). Cases are shown in rows and genes in columns. Mutations and CCF are color‐coded according to the legend. (D) Mutation‐based phylogenetic tree of case JuP3 depicting the clonal evolution of JP and synchronously identified DCIS and IDC‐NST. The lengths of the trunk and branches are proportional to the number of synonymous and nonsynonymous mutations shared or private to a given histologic component. Mutational signatures identified in the different histologic components of case JuP3 using SigMA are depicted in pie charts. The numbers of synonymous and nonsynonymous mutations of each histologic component are shown in parentheses.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-5" position="float" orientation="portrait" xlink:href="CJP2-7-113-g003.jpg"/>
        </fig>
        <p>Mutational signature analysis revealed that JP harbored a dominant aging‐related signature 5 (signature exposure of 76%) followed by signature 2 (APOBEC; signature exposure of 20%). The DCIS and IDC‐NST from JuP3, however, displayed a greater number of mutations than benign JP as well as a greater mutational signature 2 exposure (DCIS: 55%; IDC‐NST: 64%), suggesting that the development of carcinoma in this case might be associated with an increase in APOBEC mutagenesis (Figure <xref rid="cjp2190-fig-0003" ref-type="fig">3D</xref>).</p>
      </sec>
      <sec id="cjp2190-sec-0006">
        <title>Discussion</title>
        <p>Here we provide evidence that JP shows recurrent <italic toggle="yes">PIK3CA</italic> mutations, and that it may constitute the substrate from which DCIS and invasive breast cancers develop, given that we documented clonal relatedness between JP and associated carcinoma.</p>
        <p>Mutations in the PI3K‐AKT pathway, which are commonly seen in invasive breast carcinoma, have also been identified in a variety of benign proliferative epithelial lesions, including papillary neoplasms, usual ductal hyperplasia, and columnar cell change, among others [<xref rid="cjp2190-bib-0030" ref-type="ref">30</xref>, <xref rid="cjp2190-bib-0031" ref-type="ref">31</xref>]. WES analysis of the proliferative components of JP resulted in the identification of clonal <italic toggle="yes">PIK3CA</italic> hotspot mutations in 2 of 3 cases studied. We also observed a germline <italic toggle="yes">PIK3CA</italic> variant affecting the C2 domain in the third case. Although mutations affecting the C2 domain of <italic toggle="yes">PIK3CA</italic> have been reported to increase its kinase activity [<xref rid="cjp2190-bib-0032" ref-type="ref">32</xref>], the I391M germline mutation has a frequency of 6% in the normal population. Hence, its significance is uncertain. Our study confirms the findings of Guillet <italic toggle="yes">et al</italic> [<xref rid="cjp2190-bib-0003" ref-type="ref">3</xref>], who recently reported <italic toggle="yes">PIK3CA</italic> and <italic toggle="yes">AKT1</italic> mutations in 5 of 10 and 2 of 10 cases of JP, respectively. In our study and that of Guillet <italic toggle="yes">et al</italic> [<xref rid="cjp2190-bib-0003" ref-type="ref">3</xref>], it was the epithelial hyperplastic component of JP that was sequenced. It is unclear whether these mutations would be evident in other components of JP. Nonetheless, these studies expand the spectrum of benign breast lesions harboring mutations affecting PI3K‐AKT pathway‐related genes to include JP.</p>
        <p>Interestingly, there are rare reports of JP occurring in patients with Cowden syndrome and Proteus syndrome [<xref rid="cjp2190-bib-0005" ref-type="ref">5</xref>], two syndromes affecting genes in the PI3K pathway. Patients with Cowden syndrome, caused by a germline <italic toggle="yes">PTEN</italic> mutation, develop hamartomatous lesions and are at risk of multiple cancers [<xref rid="cjp2190-bib-0033" ref-type="ref">33</xref>]. Proteus syndrome, characterized by progressive asymmetric growth of multiple tissue types, is caused by somatic mosaicism for an activating <italic toggle="yes">AKT1</italic> mutation [<xref rid="cjp2190-bib-0034" ref-type="ref">34</xref>]. The presence of PI3K pathway mutations among these disorders suggests a possible link to the development of JP. Study of such lesions, however, is challenging due to their rarity.</p>
        <p>Our study not only confirms the presence of <italic toggle="yes">PIK3CA</italic> hotspot mutations in JP, but also expands our understanding of the molecular relationship between JP and breast cancer, given that here we demonstrated in one case the presence of a clonal E542K <italic toggle="yes">PIK3CA</italic> hotspot mutation shared by separate components of JP, DCIS, and IDC‐NST. The IDC‐NST component was ER‐positive/HER2‐negative with no distinctive histologic features and displayed CNAs typical of ER‐positive disease. Other types of breast carcinoma including invasive lobular carcinoma [<xref rid="cjp2190-bib-0005" ref-type="ref">5</xref>] and secretory carcinoma [<xref rid="cjp2190-bib-0001" ref-type="ref">1</xref>, <xref rid="cjp2190-bib-0035" ref-type="ref">35</xref>] have been reported in association with JP. Classic lobular carcinomas are usually ER‐positive/HER2‐negative tumors driven by <italic toggle="yes">CDH1</italic> alterations and <italic toggle="yes">PIK3CA</italic> mutations [<xref rid="cjp2190-bib-0036" ref-type="ref">36</xref>], whereas secretory carcinoma is a low‐grade triple‐negative breast cancer with a recurrent <italic toggle="yes">ETV6‐NTRK3</italic> fusion gene and is not driven by PI3K pathway alterations [<xref rid="cjp2190-bib-0037" ref-type="ref">37</xref>]. Whether JP shows similar genetic alterations as or is clonally related to associated special types of breast carcinoma driven by other molecular mechanisms is uncertain.</p>
        <p>Finally, we observed a greater exposure to an APOBEC signature in <italic toggle="yes">in situ</italic> and invasive carcinoma, compared with JP, which showed a dominant exposure to an aging signature. Our observations suggest that APOBEC mutational processes might underpin the evolution of JP to the associated DCIS and IDC‐NST components, in a way akin to the shifts from aging‐related signatures to APOBEC‐related mutagenesis in the progression from lobular carcinoma <italic toggle="yes">in situ</italic> to invasive lobular cancer [<xref rid="cjp2190-bib-0007" ref-type="ref">7</xref>] and from primary tumors to metastasis [<xref rid="cjp2190-bib-0038" ref-type="ref">38</xref>].</p>
        <p>This study has several limitations, including its small sample size due to the rarity of JP and only one of three JPs analyzed was associated with <italic toggle="yes">in situ</italic> and invasive carcinoma. Although we provide a proof‐of‐principle that JP may constitute the substrate from which DCIS and invasive breast cancers may develop, further studies are required to ascertain the frequency of this phenomenon. Despite these limitations, here we confirm the presence of recurrent <italic toggle="yes">PIK3CA</italic> mutations in JP and provide evidence that JP and coexisting carcinoma are clonally related, further expanding our understanding of the relationship between JP and breast cancer.</p>
      </sec>
      <sec id="cjp2190-sec-0008">
        <title>Author contributions statement</title>
        <p>TMD, FP, EB, BW and JSR‐F conceived the study. TMD, EC and SAH provided samples. TMD, FP, MV, EC, SAH, YHW, EB and JSR‐F performed histopathological review. MV conducted the sample processing. ADCP, AG and LF performed the bioinformatics analysis. TMD, FP, ADCP, MV, AG, EMdS, BW and JSR‐F discussed and interpreted the results. TMD, FP and MV wrote the first draft. ADCP, AG, LF, EMdS, EC, LS, SC, HZ, SAH, YHW, EB, BW and JSR‐F read, edited, and approved the final manuscript.</p>
      </sec>
    </body>
    <back>
      <ack id="cjp2190-sec-0007">
        <title>Acknowledgements</title>
        <p>This study was funded by the Breast Cancer Research Foundation. Research reported in this publication was funded in part by a Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute (Grant No. P30CA008748). FP is partially funded by a National Institutes of Health/National Cancer Institute K12 CA184746 grant and BW by Cycle for Survival and Stand Up To Cancer grants. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
      </ack>
      <sec id="cjp2190-sec-0103" sec-type="data-availability">
        <title>Data availability statement</title>
        <p>Whole‐exome sequencing data that support the findings of this study are available for visualization and download in cBioPortal for Cancer Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cbioportal.org/study/summary?id=brca_jup_msk_2020" specific-use="software is-supplemented-by">https://www.cbioportal.org/study/summary?id=brca_jup_msk_2020</ext-link>
</p>
      </sec>
      <ref-list id="cjp2190-bibl-0001" content-type="cited-references">
        <title>References</title>
        <ref id="cjp2190-bib-0001">
          <label>1</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0001"><string-name name-style="western"><surname>Rosen</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Cantrell</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Mullen</surname><given-names>DL</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Juvenile papillomatosis (Swiss cheese disease) of the breast</article-title>. <source xml:lang="en">Am J Surg Pathol</source><year>1980</year>; <volume>4:</volume><fpage>3</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">7361994</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0002">
          <label>2</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0002"><string-name name-style="western"><surname>Rosen</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Lyngholm</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Kinne</surname><given-names>DW</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Juvenile papillomatosis of the breast and family history of breast carcinoma</article-title>. <source xml:lang="en">Cancer</source><year>1982</year>; <volume>49:</volume><fpage>2591</fpage>–<lpage>2595</lpage>.<pub-id pub-id-type="pmid">7074576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19820615)49:12&lt;2591::aid-cncr2820491230&gt;3.0.co;2-o</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0003">
          <label>3</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0003"><string-name name-style="western"><surname>Guillet</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Rechsteiner</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Bellini</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations</article-title>. <source xml:lang="en">Hum Pathol</source><year>2020</year>; <volume>98:</volume><fpage>64</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="pmid">32088208</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.humpath.2020.02.002</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0004">
          <label>4</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0004"><string-name name-style="western"><surname>Rosen</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lesser</surname><given-names>ML</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Juvenile papillomatosis and breast carcinoma</article-title>. <source xml:lang="en">Cancer</source><year>1985</year>; <volume>55:</volume><fpage>1345</fpage>–<lpage>1352</lpage>.<pub-id pub-id-type="pmid">3971303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1097-0142(19850315)55:6&lt;1345::aid-cncr2820550631&gt;3.0.co;2-b</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0005">
          <label>5</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0005"><string-name name-style="western"><surname>Cheng</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>D'Alfonso</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Patel</surname><given-names>A</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Mammary juvenile papillomatosis ("Swiss cheese" disease): study of 121 cases reiterates need for long‐term follow‐up</article-title>. <source xml:lang="en">Breast J</source><year>2018</year>; <volume>24:</volume><fpage>1136</fpage>–<lpage>1137</lpage>.<pub-id pub-id-type="pmid">30051564</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/tbj.13092</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0006">
          <label>6</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0006"><string-name name-style="western"><surname>Pareja</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Brown</surname><given-names>DN</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JY</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Whole‐exome sequencing analysis of the progression from non‐low‐grade ductal carcinoma in situ to invasive ductal carcinoma</article-title>. <source xml:lang="en">Clin Cancer Res</source><year>2020</year>; <volume>26:</volume><fpage>3682</fpage>–<lpage>3693</lpage>.<pub-id pub-id-type="pmid">32220886</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-19-2563</pub-id><pub-id pub-id-type="pmcid">PMC7367727</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0007">
          <label>7</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0007"><string-name name-style="western"><surname>Li</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Durbin</surname><given-names>R</given-names></string-name>. <article-title>Fast and accurate short read alignment with burrows‐wheeler transform</article-title>. <source xml:lang="en">Bioinformatics</source><year>2009</year>; <volume>25:</volume><fpage>1754</fpage>–<lpage>1760</lpage>.<pub-id pub-id-type="pmid">19451168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmcid">PMC2705234</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0008">
          <label>8</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0008"><string-name name-style="western"><surname>McKenna</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hanna</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Banks</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>The genome analysis toolkit: a MapReduce framework for analyzing next‐generation DNA sequencing data</article-title>. <source xml:lang="en">Genome Res</source><year>2010</year>; <volume>20:</volume><fpage>1297</fpage>–<lpage>1303</lpage>.<pub-id pub-id-type="pmid">20644199</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.107524.110</pub-id><pub-id pub-id-type="pmcid">PMC2928508</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0009">
          <label>9</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0009"><string-name name-style="western"><surname>Cibulskis</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Lawrence</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Carter</surname><given-names>SL</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples</article-title>. <source xml:lang="en">Nat Biotechnol</source><year>2013</year>; <volume>31:</volume><fpage>213</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">23396013</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.2514</pub-id><pub-id pub-id-type="pmcid">PMC3833702</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0010">
          <label>10</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0010"><string-name name-style="western"><surname>Saunders</surname><given-names>CT</given-names></string-name>, <string-name name-style="western"><surname>Wong</surname><given-names>WS</given-names></string-name>, <string-name name-style="western"><surname>Swamy</surname><given-names>S</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Strelka: accurate somatic small‐variant calling from sequenced tumor‐normal sample pairs</article-title>. <source xml:lang="en">Bioinformatics</source><year>2012</year>; <volume>28:</volume><fpage>1811</fpage>–<lpage>1817</lpage>.<pub-id pub-id-type="pmid">22581179</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bioinformatics/bts271</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0011">
          <label>11</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0011"><string-name name-style="western"><surname>Koboldt</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Larson</surname><given-names>DE</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing</article-title>. <source xml:lang="en">Genome Res</source><year>2012</year>; <volume>22:</volume><fpage>568</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">22300766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/gr.129684.111</pub-id><pub-id pub-id-type="pmcid">PMC3290792</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0012">
          <label>12</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0012"><string-name name-style="western"><surname>Narzisi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>O'Rawe</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Iossifov</surname><given-names>I</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Accurate de novo and transmitted indel detection in exome‐capture data using microassembly</article-title>. <source xml:lang="en">Nat Methods</source><year>2014</year>; <volume>11:</volume><fpage>1033</fpage>–<lpage>1036</lpage>.<pub-id pub-id-type="pmid">25128977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nmeth.3069</pub-id><pub-id pub-id-type="pmcid">PMC4180789</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0013">
          <label>13</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0013"><string-name name-style="western"><surname>Narzisi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Corvelo</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Arora</surname><given-names>K</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Genome‐wide somatic variant calling using localized colored de Bruijn graphs</article-title>. <source xml:lang="en">Commun Biol</source><year>2018</year>; <volume>1:</volume><elocation-id>20</elocation-id>.<pub-id pub-id-type="pmid">30271907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-018-0023-9</pub-id><pub-id pub-id-type="pmcid">PMC6123722</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0014">
          <label>14</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0014"><string-name name-style="western"><surname>Ashley</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Da Cruz Paula</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>R</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression</article-title>. <source xml:lang="en">Gynecol Oncol</source><year>2019</year>; <volume>152:</volume><fpage>11</fpage>–<lpage>19</lpage>.<pub-id pub-id-type="pmid">30415991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ygyno.2018.10.032</pub-id><pub-id pub-id-type="pmcid">PMC6726428</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0015">
          <label>15</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0015"><string-name name-style="western"><surname>Thorvaldsdottir</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Robinson</surname><given-names>JT</given-names></string-name>, <string-name name-style="western"><surname>Mesirov</surname><given-names>JP</given-names></string-name>. <article-title>Integrative genomics viewer (IGV): high‐performance genomics data visualization and exploration</article-title>. <source xml:lang="en">Brief Bioinform</source><year>2013</year>; <volume>14:</volume><fpage>178</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">22517427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbs017</pub-id><pub-id pub-id-type="pmcid">PMC3603213</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0016">
          <label>16</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0016"><string-name name-style="western"><surname>Carter</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Cibulskis</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Helman</surname><given-names>E</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Absolute quantification of somatic DNA alterations in human cancer</article-title>. <source xml:lang="en">Nat Biotechnol</source><year>2012</year>; <volume>30:</volume><fpage>413</fpage>–<lpage>421</lpage>.<pub-id pub-id-type="pmid">22544022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.2203</pub-id><pub-id pub-id-type="pmcid">PMC4383288</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0017">
          <label>17</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0017"><string-name name-style="western"><surname>Geyer</surname><given-names>FC</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Papanastasiou</surname><given-names>AD</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Recurrent hotspot mutations in HRAS Q61 and PI3K‐AKT pathway genes as drivers of breast adenomyoepitheliomas</article-title>. <source xml:lang="en">Nat Commun</source><year>2018</year>; <volume>9:</volume><fpage>1816</fpage>.<pub-id pub-id-type="pmid">29739933</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-04128-5</pub-id><pub-id pub-id-type="pmcid">PMC5940840</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0018">
          <label>18</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0018"><string-name name-style="western"><surname>Weigelt</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Bi</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Kumar</surname><given-names>R</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>The landscape of somatic genetic alterations in breast cancers from ATM Germline mutation carriers</article-title>. <source xml:lang="en">J Natl Cancer Inst</source><year>2018</year>; <volume>110:</volume><fpage>1030</fpage>–<lpage>1034</lpage>.<pub-id pub-id-type="pmid">29506079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djy028</pub-id><pub-id pub-id-type="pmcid">PMC6136925</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0019">
          <label>19</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0019"><string-name name-style="western"><surname>Landau</surname><given-names>DA</given-names></string-name>, <string-name name-style="western"><surname>Carter</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Stojanov</surname><given-names>P</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Evolution and impact of subclonal mutations in chronic lymphocytic leukemia</article-title>. <source xml:lang="en">Cell</source><year>2013</year>; <volume>152:</volume><fpage>714</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">23415222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2013.01.019</pub-id><pub-id pub-id-type="pmcid">PMC3575604</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0020">
          <label>20</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0020"><string-name name-style="western"><surname>Ng</surname><given-names>CKY</given-names></string-name>, <string-name name-style="western"><surname>Piscuoglio</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Geyer</surname><given-names>FC</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>The landscape of somatic genetic alterations in Metaplastic breast carcinomas</article-title>. <source xml:lang="en">Clin Cancer Res</source><year>2017</year>; <volume>23:</volume><fpage>3859</fpage>–<lpage>3870</lpage>.<pub-id pub-id-type="pmid">28153863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-16-2857</pub-id><pub-id pub-id-type="pmcid">PMC5511565</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0021">
          <label>21</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0021"><string-name name-style="western"><surname>Shen</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Seshan</surname><given-names>VE</given-names></string-name>. <article-title>FACETS: allele‐specific copy number and clonal heterogeneity analysis tool for high‐throughput DNA sequencing</article-title>. <source xml:lang="en">Nucleic Acids Res</source><year>2016</year>; <volume>44:</volume><elocation-id>e131</elocation-id>.<pub-id pub-id-type="pmid">27270079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw520</pub-id><pub-id pub-id-type="pmcid">PMC5027494</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0022">
          <label>22</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0022"><string-name name-style="western"><surname>Chang</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Asthana</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gao</surname><given-names>SP</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity</article-title>. <source xml:lang="en">Nat Biotechnol</source><year>2016</year>; <volume>34:</volume><fpage>155</fpage>–<lpage>163</lpage>.<pub-id pub-id-type="pmid">26619011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nbt.3391</pub-id><pub-id pub-id-type="pmcid">PMC4744099</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0023">
          <label>23</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0023"><string-name name-style="western"><surname>Gulhan</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>JJ</given-names></string-name>, <string-name name-style="western"><surname>Melloni</surname><given-names>GEM</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Detecting the mutational signature of homologous recombination deficiency in clinical samples</article-title>. <source xml:lang="en">Nat Genet</source><year>2019</year>; <volume>51:</volume><fpage>912</fpage>–<lpage>919</lpage>.<pub-id pub-id-type="pmid">30988514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-019-0390-2</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0024">
          <label>24</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0024"><string-name name-style="western"><surname>Smith</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Da Cruz Paula</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Cadoo</surname><given-names>KA</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Endometrial cancers in BRCA1 or BRCA2 Germline mutation carriers: assessment of homologous recombination DNA repair defects</article-title>. <source xml:lang="en">JCO Precision Oncology</source><year>2019</year>: <fpage>1</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/PO.19.00103</pub-id><pub-id pub-id-type="pmcid">PMC7446423</pub-id><pub-id pub-id-type="pmid">32914019</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0025">
          <label>25</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0025"><string-name name-style="western"><surname>Reiter</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Makohon‐Moore</surname><given-names>AP</given-names></string-name>, <string-name name-style="western"><surname>Gerold</surname><given-names>JM</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Reconstructing metastatic seeding patterns of human cancers</article-title>. <source xml:lang="en">Nat Commun</source><year>2017</year>; <volume>8:</volume><elocation-id>14114</elocation-id>.<pub-id pub-id-type="pmid">28139641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ncomms14114</pub-id><pub-id pub-id-type="pmcid">PMC5290319</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0026">
          <label>26</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0026"><string-name name-style="western"><surname>Lee</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Schizas</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Geyer</surname><given-names>FC</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Lobular carcinomas in situ display Intralesion genetic heterogeneity and clonal evolution in the progression to invasive lobular carcinoma</article-title>. <source xml:lang="en">Clin Cancer Res</source><year>2019</year>; <volume>25:</volume><fpage>674</fpage>–<lpage>686</lpage>.<pub-id pub-id-type="pmid">30185420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1078-0432.CCR-18-1103</pub-id><pub-id pub-id-type="pmcid">PMC6726436</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0027">
          <label>27</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0027"><string-name name-style="western"><surname>Schultheis</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Ng</surname><given-names>CK</given-names></string-name>, <string-name name-style="western"><surname>De Filippo</surname><given-names>MR</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Massively parallel sequencing‐based Clonality analysis of synchronous Endometrioid endometrial and ovarian carcinomas</article-title>. <source xml:lang="en">J Natl Cancer Inst</source><year>2016</year>; <volume>108:</volume><elocation-id>djv427</elocation-id>.<pub-id pub-id-type="pmid">26832770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jnci/djv427</pub-id><pub-id pub-id-type="pmcid">PMC4909128</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0028">
          <label>28</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0028"><string-name name-style="western"><surname>Natrajan</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Lambros</surname><given-names>MBK</given-names></string-name>, <string-name name-style="western"><surname>Geyer</surname><given-names>FC</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with a luminal phenotype?</article-title><source xml:lang="en">Genes Chromosomes Cancer</source><year>2009</year>; <volume>48:</volume><fpage>351</fpage>–<lpage>365</lpage>.<pub-id pub-id-type="pmid">19156836</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gcc.20646</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0029">
          <label>29</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0029"><string-name name-style="western"><surname>Bersini</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lytle</surname><given-names>NK</given-names></string-name>, <string-name name-style="western"><surname>Schulte</surname><given-names>R</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Nup93 Regulates breast tumor growth by modulating cell proliferation and Actin cytoskeleton remodeling</article-title>. <source xml:lang="en">Life Sci Alliance</source><year>2020</year>; <volume>3:</volume><elocation-id>e201900623</elocation-id>.<pub-id pub-id-type="pmid">31959624</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.26508/lsa.201900623</pub-id><pub-id pub-id-type="pmcid">PMC6971368</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0030">
          <label>30</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0030"><string-name name-style="western"><surname>Ang</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Warrick</surname><given-names>AL</given-names></string-name>, <string-name name-style="western"><surname>Shilling</surname><given-names>A</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Frequent phosphatidylinositol‐3‐kinase mutations in proliferative breast lesions</article-title>. <source xml:lang="en">Mod Pathol</source><year>2014</year>; <volume>27:</volume><fpage>740</fpage>–<lpage>750</lpage>.<pub-id pub-id-type="pmid">24186142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/modpathol.2013.197</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0031">
          <label>31</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0031"><string-name name-style="western"><surname>Troxell</surname><given-names>ML</given-names></string-name>, <string-name name-style="western"><surname>Levine</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Beadling</surname><given-names>C</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast</article-title>. <source xml:lang="en">Mod Pathol</source><year>2010</year>; <volume>23:</volume><fpage>27</fpage>–<lpage>37</lpage>.<pub-id pub-id-type="pmid">19898424</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/modpathol.2009.142</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0032">
          <label>32</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0032"><string-name name-style="western"><surname>Gymnopoulos</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Elsliger</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Vogt</surname><given-names>PK</given-names></string-name>. <article-title>Rare cancer‐specific mutations in PIK3CA show gain of function</article-title>. <source xml:lang="en">Proc Natl Acad Sci U S A</source><year>2007</year>; <volume>104:</volume><fpage>5569</fpage>–<lpage>5574</lpage>.<pub-id pub-id-type="pmid">17376864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0701005104</pub-id><pub-id pub-id-type="pmcid">PMC1838453</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0033">
          <label>33</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0033"><string-name name-style="western"><surname>Bubien</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Bonnet</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Brouste</surname><given-names>V</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome</article-title>. <source xml:lang="en">J Med Genet</source><year>2013</year>; <volume>50:</volume><fpage>255</fpage>–<lpage>263</lpage>.<pub-id pub-id-type="pmid">23335809</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jmedgenet-2012-101339</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0034">
          <label>34</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0034"><string-name name-style="western"><surname>Lindhurst</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Sapp</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Teer</surname><given-names>JK</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>A mosaic activating mutation in AKT1 associated with the Proteus syndrome</article-title>. <source xml:lang="en">N Engl J Med</source><year>2011</year>; <volume>365:</volume><fpage>611</fpage>–<lpage>619</lpage>.<pub-id pub-id-type="pmid">21793738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1104017</pub-id><pub-id pub-id-type="pmcid">PMC3170413</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0035">
          <label>35</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0035"><string-name name-style="western"><surname>Tokunaga</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wakimoto</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Muramoto</surname><given-names>Y</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Juvenile secretory carcinoma and juvenile papillomatosis</article-title>. <source xml:lang="en">Jpn J Clin Oncol</source><year>1985</year>; <volume>15:</volume><fpage>457</fpage>–<lpage>465</lpage>.<pub-id pub-id-type="pmid">4021123</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0036">
          <label>36</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0036"><string-name name-style="western"><surname>Buttitta</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Felicioni</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Barassi</surname><given-names>F</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma</article-title>. <source xml:lang="en">J Pathol</source><year>2006</year>; <volume>208:</volume><fpage>350</fpage>–<lpage>355</lpage>.<pub-id pub-id-type="pmid">16353168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/path.1908</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0037">
          <label>37</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0037"><string-name name-style="western"><surname>Krings</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Joseph</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Bean</surname><given-names>GR</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas</article-title>. <source xml:lang="en">Mod Pathol</source><year>2017</year>; <volume>30:</volume><fpage>1086</fpage>–<lpage>1099</lpage>.<pub-id pub-id-type="pmid">28548128</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/modpathol.2017.32</pub-id></mixed-citation>
        </ref>
        <ref id="cjp2190-bib-0038">
          <label>38</label>
          <mixed-citation publication-type="journal" id="cjp2190-cit-0038"><string-name name-style="western"><surname>Angus</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Smid</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Wilting</surname><given-names>SM</given-names></string-name>, <italic toggle="yes">et al</italic><article-title>The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies</article-title>. <source xml:lang="en">Nat Genet</source><year>2019</year>; <volume>51:</volume><fpage>1450</fpage>–<lpage>1458</lpage>.<pub-id pub-id-type="pmid">31570896</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-019-0507-7</pub-id><pub-id pub-id-type="pmcid">PMC6858873</pub-id></mixed-citation>
        </ref>
      </ref-list>
    </back>
  </article>
</pmc-articleset>
